Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-18

Clinical Trial Update: Skin bioMARkers for Atopic Eczema Therapy Evaluation [Phase 2]

View source ↗

Summary

Update on a Phase 2 trial evaluating skin biomarkers for therapy assessment in atopic dermatitis; the trial has completed and results were posted in 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust | Conditions: Atopic Eczema/Dermatitis (Non-Specific) | Phase 2 | Status: COMPLETED | Results posted: 2025-07-18